1. Home
  2. EOT vs ORGO Comparison

EOT vs ORGO Comparison

Compare EOT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

EOT

Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

HOLD

Current Price

$17.52

Market Cap

264.2M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.86

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EOT
ORGO
Founded
N/A
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.2M
299.8M
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
EOT
ORGO
Price
$17.52
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
24.5K
708.8K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.04
52 Week Low
$15.97
$2.04
52 Week High
$18.00
$7.08

Technical Indicators

Market Signals
Indicator
EOT
ORGO
Relative Strength Index (RSI) 58.59 47.59
Support Level $17.13 $2.26
Resistance Level $17.89 $2.63
Average True Range (ATR) 0.27 0.13
MACD 0.02 -0.02
Stochastic Oscillator 72.00 29.11

Price Performance

Historical Comparison
EOT
ORGO

About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. The company invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: